Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Jusung Engineering (036930) – Investor Relations (IR) Presentation / 2025-08-25

Posted on August 25, 2025August 3, 2026 By K-STOCK Editor No Comments on [Disclosure] Jusung Engineering (036930) – Investor Relations (IR) Presentation / 2025-08-25

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Jusung Engineering has announced that it will host a domestic Non-Deal Roadshow (NDR) in Seoul on August 25, 2025, for institutional investors and analysts to review H1 2025 financial results and business operations.

📊 [Key Disclosure Contents & Summary Metrics]

  • Date & Time: August 25, 2025 (09:00 – 17:00 KST)
  • Location: Seoul (Gwanghwamun, Yeouido, etc.)
  • Target Audience: Domestic and overseas institutional investors, securities analysts, etc.
  • Purpose: Domestic NDR (To enhance investor understanding of the company’s technology and business strategy)
  • Method: 1-on-1 in-person meetings
  • Key Topics:
    • Comments on H1 2025 financial performance
    • Presentation on major business operations and Q&A session
  • Sponsoring Institution: Samsung Securities
  • IR Materials Upload:
    • Upload Date: August 25, 2025
    • Upload Location: Jusung Engineering official website (IR section) & KRX KIND system

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of IR Presentation Materials and Session Details

This disclosure serves as an official announcement regarding an NDR hosted for institutional investors and analysts to review H1 2025 financial results and business operations. Checking the official presentation materials uploaded regarding H1 2025 performance comments and business updates is recommended. Detailed presentation materials can be verified via the official company website’s IR section or the KRX KIND disclosure portal.

📢 Disclaimer & Source Notice

Source: This content is structured and rewritten based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Samsung Biologics (207940) – (Correction) Decision on Corporate Spin-off / 2025-08-22
Next Post: [Disclosure] Jusung Engineering (036930) – Investor Relations (IR) Presentation / 2025-08-25

Related Posts

[Disclosure] Wonik IPS (240810) – Decision on Cash and Non-Cash Dividend / 2025-02-26 Semiconductors
[Disclosure] Samsung Electronics (005930) – Other Management Matters (Voluntary Disclosure) / 2025-10-30 Semiconductors
[Disclosure] Samsung Biologics (207940) – Setting of Record Date or Period for Closure of Shareholder Register / 2025-07-14 Disclosures
[Disclosure] SK hynix(000660) – Decision on Calling of General Shareholders’ Meeting / 2024-03-06 Disclosures
[Disclosure] ALTEOGEN (196170) – Result of Securities Issuance (Voluntary Disclosure) / 2025-02-19 Disclosures
[Disclosure] Samsung Biologics (207940) – Advance Notice of Financial Results Announcement / 2025-04-09 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Aerospace (012450) – Decision on Convening General Meeting of Shareholders / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Aerospace (012450) – Setting of Record Date for Shareholder Register Closure / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme